主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SMMT
#672
Summit Therapeutics Inc. Common Stock
16.590
0
+7.66%
版块:
基础:
利润货币:
日范围
年范围
日变化
+7.66%
每月变动
+4.60%
6个月变化
-16.47%
年变化
-16.47%
前一天收盘价
15.410
0
Open
16.590
0
Bid
Ask
Low
16.590
0
High
16.590
0
交易量
263
市场
股票
医疗保健
SMMT
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.31 M
192.16 M
3.14 B
1.78 B
13.06 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
21.44 K
299.49 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.51
0.78
0.12
3.03
0.51
1.44
3.09
Return on equity %
0.66
1.06
0.62
7.91
0.57
1.64
3.9
Return on invested capital %
831.34
1 235.4
172.33
1 492.71
3 507.86
-10.83 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
6 185.23
4 764.29
10.23 K
—
—
-179.31 K
382.99 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
6 127.56
4 897.84
11.17 K
—
—
176.98 K
-368.23 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
0.69
0.79
0.22
0.12
0.2
0.43
0.43
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.22
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.95
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
新闻
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. Wainwright因中国试验时间不确定性下调Summit Therapeutics目标价
H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Citizens重申Summit Therapeutics评级,看好管线扩张
Citizens reiterates Summit Therapeutics stock rating on pipeline expansion
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript
Summit Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SMMT) 2026-02-23
Summit 2025年第四季度业绩:临床进展亮眼但每股收益不及预期389%
Summit Q4 2025 slides: clinical wins offset by 389% EPS miss
Earnings call transcript: Summit Therapeutics Q4 2025 reports significant EPS miss
Summit Therapeutics财报未及预期股价下跌,尽管项目取得进展